ABIO
Closed
Arca Biopharma Inc
2.11
+0.01 (+0.48%)
Last Update: 02 Jun 2023 22:59:00
Yesterday: 2.1
Day's Range: 2.01 - 2.11
Send
sign up or login to leave a comment!
When Written:
1.99
ARCA Biopharma Inc is a biopharmaceutical company that focuses on developing genetically targeted therapies for cardiovascular diseases. The company's lead product candidate is Gencaro, a beta-blocker and mild vasodilator that is being developed for the treatment of atrial fibrillation (AF) in patients with heart failure and reduced left ventricular ejection fraction.
ARCA Biopharma's technology platform includes a proprietary algorithm that identifies genetic variations that may affect drug response. The company's goal is to develop personalized treatments that are more effective and have fewer side effects than conventional therapies.
ARCA Biopharma was founded in 1998 and is headquartered in Westminster, Colorado. The company is publicly traded on the NASDAQ exchange under the ticker symbol ABIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
ARCA Biopharma's technology platform includes a proprietary algorithm that identifies genetic variations that may affect drug response. The company's goal is to develop personalized treatments that are more effective and have fewer side effects than conventional therapies.
ARCA Biopharma was founded in 1998 and is headquartered in Westminster, Colorado. The company is publicly traded on the NASDAQ exchange under the ticker symbol ABIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!